All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • MNV-201Phase 21 trial

    Minovia Therapeutics Ltd. · Mitochondrial Diseases, Pearson Syndrome

  • MocaciclibQ901Phase 21 trial

    Qurient Co., Ltd. · Advanced Cancer, Metastatic Cancer

  • MPB-1734DMB025Phase 21 trial

    MegaPro Biomedical Co. Ltd. · Solid Tumor, Unspecified, Adult

  • MR001Phase 21 trial

    Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC)

  • MRG-001Phase 21 trial

    MedRegen LLC · Alcoholic Hepatitis, Acute Alcoholic Hepatitis

  • MRG007Phase 21 trial

    Lepu Biopharma Co., Ltd. · Advanced Colorectal Cancer

  • MS-553Phase 21 trial

    MingSight Pharmaceuticals, Inc · CLL (Chronic Lymphocytic Leukemia), SLL (Small Lymphocytic Lymphoma)

  • MT-201Phase 21 trial

    Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • MT-501Phase 21 trial

    Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease

  • MT101-5Phase 21 trial

    Mthera Pharma Co., Ltd. · Parkinson's Disease

  • MT1988Phase 21 trial

    Monument Therapeutics Limited · Clinical High Risk for Psychosis (CHR)

  • MT200605Phase 21 trial

    Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Acute Ischemic Stroke

  • MT218Phase 21 trial

    Songqi Gao · MRI Scan

  • MTX-001human amniotic fluidPhase 21 trial

    Merakris Therapeutics · Venous Stasis Ulcer, Venous Leg Ulcer

  • MTX-463Phase 21 trial

    Mediar Therapeutics · Idiopathic Pulmonary Fibrosis

  • MTX-474Phase 21 trial

    Mediar Therapeutics · Diffuse Cutaneous Systemic Sclerosis

  • MTX101Phase 21 trial

    Manistee Therapeutics · Migraine

  • MVA-209-FSPPhase 21 trial

    Nouscom SRL · Solid Tumor, Adult

  • MWX203Phase 21 trial

    Shanghai Minwei Biotechnology Co., Ltd · Mixed Dyslipidemia

  • MZE782Phase 21 trial

    Maze Therapeutics · Phenylketonuria (PKU)

  • MZE829Phase 21 trial

    Maze Therapeutics · Proteinuric Kidney Disease

  • N17350Phase 21 trial

    Onchilles Pharma Inc · Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin

  • Nab-placlitaxelPhase 21 trial

    BioNTech SE · Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers

  • NadunolimabCAN04Phase 21 trial

    Cantargia AB · Triple Negative Breast Cancer

  • nangibotideLR12Phase 21 trial

    Inotrem · Shock, Septic

  • narmafotinibPhase 21 trial

    Amplia Therapeutics Limited · Pancreatic Cancer Metastatic

  • NAV-240Phase 21 trial

    Navigator Medicines, Inc. · Hidradenitis Suppurativa (HS)

  • NazartinibEGF816Phase 21 trial

    Novartis · Advanced Solid Tumors Which Are cMET-dependent

  • NB-4746Phase 21 trial

    Nura Bio · Amyotrophic Lateral Sclerosis (ALS)

  • NBI-1065890Phase 21 trial

    Neurocrine Biosciences · Tardive Dyskinesia

  • NBI-1070770Phase 21 trial

    Neurocrine Biosciences · Major Depressive Disorder

  • NBI-1117567Phase 21 trial

    Neurocrine Biosciences · Alzheimer's Disease

  • NBI-1117570Phase 21 trial

    Neurocrine Biosciences · Schizophrenia

  • NBIP-01435Phase 21 trial

    Neurocrine Biosciences · Congenital Adrenal Hyperplasia

  • NBQ72SQBS10072SPhase 21 trial

    Nantong Bencao Quadriga Medical Technology Co. Ltd. · Breast Cancer

  • nC-001Phase 21 trial

    nephCentric · CHRONIC HYPONATREMIA

  • NCR100Phase 21 trial

    Nuwacell Biotechnologies Co., Ltd. · Knee Osteoarthritis

  • NCR101Phase 21 trial

    Nuwacell Biotechnologies Co., Ltd. · Interstitial Lung Disease (ILD)

  • NCR102Phase 21 trial

    Nuwacell Biotechnologies Co., Ltd. · Acute Graft-versus-Host Disease

  • NCS-01Phase 21 trial

    NC Medial Research Inc · Ischemic Stroke

  • ND-003Phase 21 trial

    Shenzhen NewDEL Biotech, Co., Ltd · Idiopathic Pulmonary Fibrosis (IPF)

  • ND0612ND0612HPhase 21 trial

    NeuroDerm Ltd. · Parkinson's Disease

  • NDI-101150Phase 21 trial

    Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

  • NDI-219216Phase 21 trial

    Nimbus Wadjet, Inc. · Advanced Solid Tumors Cancer, MSI-H Cancer

  • NDX-3315Phase 21 trial

    NexEos Diagnostics, Inc. · Eosinophilic Esophagitis

  • NDX-3324Phase 21 trial

    NexEos Diagnostics, Inc. · Eosinophilic Esophagitis

  • NemvaleukinALKS 4230Phase 21 trial

    Mural Oncology, Inc · Advanced Solid Tumor

  • NEO-201Phase 21 trial

    Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer

  • NEO212POH-TMZPhase 21 trial

    Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult

NewerPage 62 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.